ロード中...

Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma

Pancreatic cancer is the only major cancer with very low survival rates (1%). It is the fourth leading cause of cancer-related death. Hyperactivated growth hormone receptor (GHR) levels have been shown to increase the risk of cancer in general and this pathway is a master regulator of key cellular f...

詳細記述

保存先:
書誌詳細
出版年:Exp Mol Med
主要な著者: Subramani, Ramadevi, Lopez-Valdez, Rebecca, Salcido, Alyssa, Boopalan, Thiyagarajan, Arumugam, Arunkumar, Nandy, Sushmita, Lakshmanaswamy, Rajkumar
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221692/
https://ncbi.nlm.nih.gov/pubmed/25301264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2014.61
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!